
Liquidia Technologies is a biotechnology business based in the US. Liquidia Technologies shares (LQDA) are listed on the NASDAQ and all prices are listed in US Dollars. Liquidia Technologies employs 52 staff and has a trailing 12-month revenue of around $13.8 million.
How to buy Liquidia Technologies stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – LQDA. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
eToro
- Easy to use platform with low fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100
Robinhood
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
Liquidia Technologies stock price (NASDAQ: LQDA)
Use our graph to track the performance of LQDA stocks over time.Liquidia Technologies shares at a glance
Latest market close | $6.97 |
---|---|
52-week range | $3.26 - $8.79 |
50-day moving average | $5.92 |
200-day moving average | $5.42 |
Wall St. target price | $13.14 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.80 |
Buy Liquidia Technologies stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Liquidia Technologies stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Liquidia Technologies price performance over time
Historical closes compared with the close of $6.97 from 2023-02-07
1 week (2023-02-02) | -0.57% |
---|---|
1 month (2023-01-09) | 20.38% |
3 months (2022-11-09) | 39.96% |
6 months (2022-08-09) | 27.42% |
1 year (2022-02-08) | 5.45% |
---|---|
2 years (2021-02-09) | 105.00% |
3 years (2020-02-07) | 15.40% |
5 years (2018-02-05) | N/A |
Liquidia Technologies financials
Revenue TTM | $13.8 million |
---|---|
Gross profit TTM | $9.8 million |
Return on assets TTM | -23.42% |
Return on equity TTM | -54.82% |
Profit margin | 0% |
Book value | $1.47 |
Market capitalisation | $412.1 million |
TTM: trailing 12 months
Liquidia Technologies share dividends
We're not expecting Liquidia Technologies to pay a dividend over the next 12 months.
Liquidia Technologies share price volatility
Over the last 12 months, Liquidia Technologies's shares have ranged in value from as little as $3.26 up to $8.79. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Liquidia Technologies's is 0.1287. This would suggest that Liquidia Technologies's shares are less volatile than average (for this exchange).
Liquidia Technologies overview
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina. .
Liquidia Technologies in the news
Decision moves Liquidia, United Therapeutics patent dispute toward resolution
Strength Seen in Liquidia Technologies, Inc. (LQDA): Can Its 9.7% Jump Turn into More Strength?
Patent Trial and Appeal Board (PTAB) Reaffirms Decision to Invalidate All Claims of United Therapeutics (UTHR) Patent No. 10,716,793 (‘793 Patent)
Frequently asked questions
What percentage of Liquidia Technologies is owned by insiders or institutions?Currently 12.097% of Liquidia Technologies shares are held by insiders and 48.025% by institutions. How many people work for Liquidia Technologies?
Latest data suggests 52 work at Liquidia Technologies. When does the fiscal year end for Liquidia Technologies?
Liquidia Technologies's fiscal year ends in December. Where is Liquidia Technologies based?
Liquidia Technologies's address is: 419 Davis Drive, Morrisville, NC, United States, 27560 What is Liquidia Technologies's ISIN number?
Liquidia Technologies's international securities identification number is: US53635D2027 What is Liquidia Technologies's CUSIP number?
Liquidia Technologies's Committee on Uniform Securities Identification Procedures number is: 53635D202
More guides on Finder
-
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Ask an Expert